FACTORS ASSOCIATED WITH PERSISTENCE OF GOLIMUMAB TREATMENT IN THE BIOBADASER REGISTRY, UP TO 7 YEARS OF FOLLOW-UP

Pombo, M.Sanchez-Piedra, C.Cea-Calvo, L.Manrique Arija, S.Garcia-Magallon, B.Campos Fernandez, C.Notario, I.Diaz-Gonzalez, F.Gomez-Reino, J. J.2025-01-072025-01-072020-06-010003-4967https://hdl.handle.net/10668/26332enFACTORS ASSOCIATED WITH PERSISTENCE OF GOLIMUMAB TREATMENT IN THE BIOBADASER REGISTRY, UP TO 7 YEARS OF FOLLOW-UPconference outputopen access10.1136/annrheumdis-2020-eular.34901468-2060https://ard.bmj.com/content/annrheumdis/79/Suppl_1/733.2.full.pdf555905002254